T cell apoptosis is another critical component of tolerSummary ance and plays an essential role at two stages in the natural life of a T cell. Developing thymocytes are in-DRAK2 is a member of the death-associated protein duced to die as a consequence of high reactivity for (DAP)-like family of serine/threonine kinases. Memself-MHC and peptide complexes, thus reducing the bers of this family induce apoptosis in various cell number of potentially autoreactive T cells that progress types. DRAK2, in particular, is specifically expressed through development. Apoptosis is also an essential in T cells and B cells, and it is differentially regulated feature of the waning phase of the immune response to during T cell development. To determine whether an infectious agent.
Introduction most abundantly in lymphoid organs. In fact, an analysis of gene expression patterns in 46 different human tisThe acquired immune system of vertebrates evolved in sues revealed that DRAK (also referred to as STK17) is response to relentless pressure applied by coevolving one of only 31 genes expressed exclusively in lymphoid infectious agents (Hedrick, 2004) 
. It is unique in exhibtissue (Su et al., 2002). iting unlimited potential for molecular recognition as well
Given that apoptosis is so critical for maintaining a as a diverse means for inducing cellular destruction. In well-regulated immune system and that members of the fact, it is the only physiological system in animals capa-DAP-like kinase family induce apoptosis, we investible of actively executing the loss of organismal integrity. gated the role of DRAK2 in lymphoid cells. In extensive Consequently, numerous mechanisms have evolved studies of Drak2 Ϫ/Ϫ mice, we found no evidence for an that regulate the activation of an immune response and alteration in the sensitivity of thymocytes or mature limit its extent and duration. This is particularly important T cells to apoptosis. Instead, we found that T cells defiat the level of T cell activation. Regulatory molecules cient in Drak2 exhibited increased sensitivity to TCR expressed in T cells participate in maintaining cellular signals with a reduced requirement for costimulation. quiescence, setting the threshold for activation and limFrom these studies we conclude that DRAK2 functions iting the magnitude of a response through negative feedas yet another negative regulator of T cell activation. selection in Drak2 Ϫ/Ϫ mice was altered in two in vivo expression is highest in B cells but is also expressed at models. First, Drak2 Ϫ/Ϫ mice were crossed to H-Y TCR high levels in both CD4 ϩ and CD8 ϩ T cells. DRAK2 is transgenic mice. This TCR is specific for a peptide from not expressed at significant levels in NK cells, macrothe male antigen bound to H-2D Figure S2 and data not shown). Together, these data suggest that DRAK2 does not play an essential role in induction of thymocyte apoptosis or negative selection.
Enhanced Positive Selection in the Absence of DRAK2
Although there was no defect in thymocyte negative selection or differences in total thymic cellularity, Drak2 Ϫ/Ϫ thymuses had a slight, yet statistically significant, increase in the percent of CD4SP thymocytes compared to wild-type (wt) mice (Supplemental Figure S3A) . This increase coincided with a concomitant decrease in the percent of DP thymocytes and was enhanced when Drak2 Ϫ/Ϫ mice were bred to mice expressing MHC class II-restricted TCR transgenes, either OT-II or AND (Supplemental Figure S3A and data not shown). However, there was no effect on subset distribution when Drak2 Ϫ/Ϫ mice were bred to OT-I or P14 mice, MHC class I-restricted TCR transgenic mice (Supplemental Figure  S3A) . Thus, the absence of Drak2 enhanced development of CD4 ϩ thymocytes but had little effect on CD8 ϩ thymocytes. In addition, the levels of CD5 and CD69 were slightly increased on OT-II;Drak2 Ϫ/Ϫ and OT-I; Drak2 Ϫ/Ϫ DP thymocytes compared to wt DP thymocytes (Supplemental Figure S3B ). This increase in CD5 and CD69 expression in the absence of Drak2 suggests that the intensity of the signal through the TCR was enhanced in Drak2 Ϫ/Ϫ thymocytes. We conclude that DRAK2 negatively regulates signals initiated through the TCR. Figure 3A ). This provides at least one explanation for the exception that the dose response was shifted to lower concentrations of agonististic anti anti-CD28 antibody. increased sensitivity of Drak2 Ϫ/Ϫ T cells to suboptimal stimuli. We also measured the amount of IL-4 and IFN␥ The net recovery of cells from these experiments was plotted as a function of the time to reflect both proliferain unpolarized and Th1/Th2 polarized T cells. Both wt and Drak2 Ϫ/Ϫ T cells produced the appropriate cytokines tion and apoptosis ( Figure 4B ). Wt CD8 ϩ T cells expanded at low concentrations of anti-CD28, whereas wt under Th1 and Th2 skewing conditions ( Figure 3B ). In addition, under nonskewing conditions, Drak2 Ϫ/Ϫ T cells CD4 ϩ T cells required 10-to 100-fold more costimulation to achieve the same cell production. This was similar produced more IFN-␥, IL4, and IL-2 compared to controls.
An Increase in
for Drak2 Ϫ/Ϫ T cells with the exception that both of the responses required even lower concentrations of antiIn addition to cytokine production, we analyzed the expression level of various costimulatory molecules on CD28. The loss of Drak2 would therefore not appear to obviate the need for costimulation, but rather T cells are purified, naive T cells before and after activation. Prior to T cell activation, the levels of the cytokine receptors, more sensitive to costimulation as measured by either proliferation or survival. Together these data demonthat responded to LCMV was not dramatic, which would be predicted for a response in which costimulation is strate that the enhanced proliferation exhibited by Drak2 Ϫ/Ϫ T cells did not arise from a defect in cell death likely to be maximal. In addition to counting the number of LCMV-specific T cells, we also measured the amount associated with activation.
of IFN-␥ in the serum during the response. Interestingly, the level of IFN-␥ present in the serum of Drak2 Ϫ/Ϫ mice The Impact of DRAK2 on an In Vivo was greater than that of wt mice before the peak of the Immune Response response and during the contraction phase ( Figure 4D ). Although there was no defect in apoptosis of Drak2 To test if other signaling molecules were altered, we stimulated OT-I;Drak2 Ϫ/Ϫ and Drak2 ϩ/ϩ T cells for 5 min with peptide-pulsed APC. In these experiments, the APC were pulsed with the agonist peptide OVAp or the suboptimal peptide G4. Consistent with an increase in calcium flux, there was also an increase in the phosphorylation of ERK1/2 and c-Jun in Drak2 Ϫ/Ϫ T cells compared to wt cells ( Figure 5D ). Like the proliferation data, the difference was greater in response to the suboptimal stimulus. Interestingly, not all TCR signaling pathways were affected as there was no difference in phosphorylation of JNK, p38, or IB-␣, a molecule in the NF-B pathway. In addition, we did not observe a difference in the phosphorylation of molecules proximal to the TCR including TCR, LCK, and ZAP70 (data not shown). Although we have not identified a molecule with which DRAK2 directly interacts, in its absence, critical pathways downstream of TCR signaling are overstimulated.
Drak2
Ϫ/Ϫ Mice Are Resistant to EAE The data presented thus far establish that DRAK2 is a negative regulator of T cell activation, and in its absence, T cells are hypersensitive to suboptimal stimuli. Based on other examples of T cell hypersensitivity, we predicted that Drak2 Ϫ/Ϫ mice would be more susceptible to autoimmune disease. To test for spontaneous autoimmunity, we aged 9 Drak2 ϩ/ϩ and 15 Drak2 Ϫ/Ϫ littermates for at least 15 months and analyzed the major organs of these mice for cellular infiltrate. In addition, we measured the amount of anti-nuclear and anti-dsDNA antibodies in the serum of the aged mice. Of the 15 Drak2 Ϫ/Ϫ mice, only one mouse had a very mild infiltrate in the pancreas. In the remaining wt and Drak2 Ϫ/Ϫ mice, there were no signs of cellular infiltration (data not shown). In addition, none of the Drak2 Ϫ/Ϫ mice had higher levels of autoantibodies than the wt littermates (data not shown). Contrary to expectations, there was no obvious increase in these indicators of autoimmune disease.
In order to test if Drak2 had an impact on induced autoimmune disease, we compared the responses of wt, Drak2 of disease were dramatically reduced in Drak2 Ϫ/Ϫ mice (Table 1 ). In accord with symptoms, Drak2 Ϫ/Ϫ mice exhibited a reduced number of infiltrating cells in the nervous system ( Figure 6B) , although there were similar numbers of MOG-specific cells in the spleen and the draining lymph nodes 20 days after immunization (data not shown). Therefore, both Drak2 Ϫ/Ϫ and Cbl-b Ϫ/Ϫ T cells were hypersensitive to suboptimal stimuli; however, the impact this hypersensitivity had on autoimmunity was completely contradictory. In fact, thus far, a deficiency in Drak2 is the only model of T cell hypersensitivity that results in a resistance to autoimmunity. Ϫ/Ϫ mice were more susceptitrol experiments showed this hypersensitivity was not ble to EAE in that a greater number of mice exhibited due to differences in APC or due to the fact that there signs of disease, and the severity of this disease was were more CD62L lo T cells in Drak2 Ϫ/Ϫ mice. Together, elevated compared to wt mice (Table 1) . Contrary to our these data reveal that DRAK2 functions to negatively expectations, Drak2 Ϫ/Ϫ mice were not more susceptible regulate signals involved in T cell activation. to EAE, but rather they were extremely resistant to disThe most surprising characteristic observed in ease ( Figure 6A ). Both the incidence and the severity Drak2 Ϫ/Ϫ mice was the resistance to EAE despite the T cell hypersensitivity. In other models of negative T cell regulation that have been tested for autoimmunity, the 
Discussion

DRAK2 is unique in that it
